◀ Back to CHUK
CHUK — NEDD9
Text-mined interactions from Literome
Lang et al., Mol Cell Biol 2003
:
IKK mediated
p105 phosphorylation generates a binding site for betaTrCP, the receptor subunit of an SCF-type ubiquitin E3 ligase, and depletion of betaTrCP by RNA interference blocks TNF-alpha induced p105 ubiquitination and proteolysis
Beinke et al., Mol Cell Biol 2004
(MAP Kinase Signaling System) :
These data show that
IKK induced
p105 proteolysis is essential for LPS activation of TPL-2, thus revealing a novel function of IKK in the regulation of the ERK MAP kinase cascade
Parameswaran et al., J Biol Chem 2006
:
Upon LPS stimulation,
IkappaB kinase promotes phosphorylation and degradation of NFkappaB1
p105 ( p105 ) , which releases TPL2 ( a MAP3K ), which phosphorylates MEK1/2, which in turn phosphorylates ERK1/2
Loniewski et al., Mol Immunol 2007
:
Furthermore, although TLR4 mediated
IKK induced
p105 phosphorylation is not sensitive to TRAF6 knockdown, I kappa B alpha phosphorylation ( also, IKK induced ) is significantly blocked, suggesting that TLR4 activation results in a TRAF6-sensitive and -insensitive IKK activation in macrophages
Sriskantharajah et al., Nat Immunol 2009
:
To investigate the importance of proteolysis of NF-kappaB1
p105 induced by the kinase
IKK in activation of the transcription factor NF-kappaB, we generated 'Nfkb1 ( SSAA/SSAA ) ' mice, in which the IKK-target serine residues of p105 were substituted with alanine
Gantke et al., Immunol Rev 2012
(Inflammation...) :
Agonist stimulation releases TPL-2 from p105-inhibition by
IKK mediated phosphorylation of
p105 , which triggers degradation of p105 by the proteasome
Yang et al., Mol Cell Biol 2012
:
Activation of TPL-2/ERK signaling by
IKK induced
p105 proteolysis, therefore, induced a negative feedback loop to downregulate NF-?B dependent expression of the proinflammatory cytokine interleukin-12 (IL-12) ... Unexpectedly, TPL-2 promoted soluble TNF production independently of
IKK induced
p105 phosphorylation and its ability to activate ERK, which has important implications for the development of anti-inflammatory drugs targeting TPL-2